Nippon Life Global Investors Americas, Inc. Biogen Inc. Transaction History

Nippon Life Global Investors Americas, Inc.

$2.22 Billion
Q2 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $1.68 Million - $1.9 Million	6,630 New	6,630 $1.7 Million
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $2.44 Million - $3.13 Million	-10,890 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$282.99 - $369.05 $430,144 - $560,956	-1,520 Reduced 12.25%	10,890 $3.08 Million
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $3.21 Million - $5.15 Million	12,410 New	12,410 $4.3 Million
Q4 2019 Jan 24, 2020	SELL	$220.06 - $304.07 $3.22 Million - $4.44 Million	-14,610 Closed	0 $0
Q2 2019 Jul 23, 2019	BUY	$219.29 - $241.72 $350,864 - $386,752	1,600 Added 12.3%	14,610 $3.42 Million
Q4 2018 Jan 17, 2019	BUY	$278.5 - $352.75 $3.62 Million - $4.59 Million	13,010 New	13,010 $3.92 Million
Q1 2018 May 09, 2018	SELL	$260.13 - $367.91 $8.04 Million - $11.4 Million	-30,900 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$307.64 - $344.58 $993,677 - $1.11 Million	3,230 Added 11.67%	30,900 $9.84 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $7.78 Million - $9.12 Million	27,670	27,670 $8.66 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nippon Life Global Investors Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nippon Life Global Investors Americas, Inc. with notifications on news.

Account